Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

T1Covered by 1 source · first reported by Economic Times — Tech / Technology / Startups / ETTelecom at 23 Oct, 13:19 UTC

Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's

aiindia

Sources

• T1Pathos AI teams up with Bristol Myers and Tempus AI to advance drug developmentEconomic Times — Tech / Technology / Startups / ETTelecom23 Oct, 13:19